Post-earnings recap
Reported
Tue, Nov 3, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.65, exceeding expectations by nearly 8%. This positive surprise contributed to a slight increase in the stock price by 0.92%. However, without additional context from management commentary or guidance, it is difficult to assess the longer-term implications of these results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.65 | N/A | +7.97% |
No transcript is on record, so the analysis is based solely on numerical results.